BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 19291701)

  • 21. IFN-gamma-STAT1 signal regulates the differentiation of inducible Treg: potential role for ROS-mediated apoptosis.
    Chang JH; Kim YJ; Han SH; Kang CY
    Eur J Immunol; 2009 May; 39(5):1241-51. PubMed ID: 19337996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune suppressive activity and lack of T helper differentiation are differentially regulated in natural regulatory T cells.
    Zeng WP; Chang C; Lai JJ
    J Immunol; 2009 Sep; 183(6):3583-90. PubMed ID: 19710452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapeutic effect of CXCR3-expressing regulatory T cells on liver, lung and intestinal damages in a murine acute GVHD model.
    Hasegawa H; Inoue A; Kohno M; Lei J; Miyazaki T; Yoshie O; Nose M; Yasukawa M
    Gene Ther; 2008 Feb; 15(3):171-82. PubMed ID: 17989707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanisms of foxp3+ T regulatory cell-mediated suppression.
    Shevach EM
    Immunity; 2009 May; 30(5):636-45. PubMed ID: 19464986
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropilin-1 is not a marker of human Foxp3+ Treg.
    Milpied P; Renand A; Bruneau J; Mendes-da-Cruz DA; Jacquelin S; Asnafi V; Rubio MT; MacIntyre E; Lepelletier Y; Hermine O
    Eur J Immunol; 2009 Jun; 39(6):1466-71. PubMed ID: 19499532
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Developmental plasticity of Foxp3+ regulatory T cells.
    Hori S
    Curr Opin Immunol; 2010 Oct; 22(5):575-82. PubMed ID: 20829012
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deficient SOCS3 expression in CD4+CD25+FoxP3+ regulatory T cells and SOCS3-mediated suppression of Treg function.
    Pillemer BB; Xu H; Oriss TB; Qi Z; Ray A
    Eur J Immunol; 2007 Aug; 37(8):2082-9. PubMed ID: 17621372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CTLA-4 (CD152) controls homeostasis and suppressive capacity of regulatory T cells in mice.
    Kolar P; Knieke K; Hegel JK; Quandt D; Burmester GR; Hoff H; Brunner-Weinzierl MC
    Arthritis Rheum; 2009 Jan; 60(1):123-32. PubMed ID: 19116935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of leukotriene B4 and prostaglandin E2 on the differentiation of murine Foxp3+ T regulatory cells and Th17 cells.
    Chen H; Qin J; Wei P; Zhang J; Li Q; Fu L; Li S; Ma C; Cong B
    Prostaglandins Leukot Essent Fatty Acids; 2009 Apr; 80(4):195-200. PubMed ID: 19264469
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adaptive Foxp3+ regulatory T cell-dependent and -independent control of allergic inflammation.
    Curotto de Lafaille MA; Kutchukhidze N; Shen S; Ding Y; Yee H; Lafaille JJ
    Immunity; 2008 Jul; 29(1):114-26. PubMed ID: 18617425
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Foxp3 as a marker of tolerance induction versus rejection.
    Zhang GY; Hu M; Wang YM; Alexander SI
    Curr Opin Organ Transplant; 2009 Feb; 14(1):40-5. PubMed ID: 19337145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thymic regulation of autoimmune disease by accelerated differentiation of Foxp3+ regulatory T cells through IL-7 signaling pathway.
    Chen X; Fang L; Song S; Guo TB; Liu A; Zhang JZ
    J Immunol; 2009 Nov; 183(10):6135-44. PubMed ID: 19841165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inducible reprogramming of human T cells into Treg cells by a conditionally active form of FOXP3.
    Allan SE; Song-Zhao GX; Abraham T; McMurchy AN; Levings MK
    Eur J Immunol; 2008 Dec; 38(12):3282-9. PubMed ID: 19039775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted therapy to the IL-2R using diphtheria toxin and caspase-3 fusion proteins modulates Treg and ameliorates inflammatory colitis.
    Yarkoni S; Sagiv Y; Kaminitz A; Farkas DL; Askenasy N
    Eur J Immunol; 2009 Oct; 39(10):2850-64. PubMed ID: 19735074
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Defective leptin/leptin receptor signaling improves regulatory T cell immune response and protects mice from atherosclerosis.
    Taleb S; Herbin O; Ait-Oufella H; Verreth W; Gourdy P; Barateau V; Merval R; Esposito B; Clément K; Holvoet P; Tedgui A; Mallat Z
    Arterioscler Thromb Vasc Biol; 2007 Dec; 27(12):2691-8. PubMed ID: 17690315
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FOXP3+ regulatory T cells: Current controversies and future perspectives.
    Banham AH; Powrie FM; Suri-Payer E
    Eur J Immunol; 2006 Nov; 36(11):2832-6. PubMed ID: 17051620
    [TBL] [Abstract][Full Text] [Related]  

  • 37. c-Rel: a pioneer in directing regulatory T-cell lineage commitment?
    Hori S
    Eur J Immunol; 2010 Mar; 40(3):664-7. PubMed ID: 20162555
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD4+Foxp3+ regulatory T-cell impairment by paclitaxel is independent of toll-like receptor 4.
    Zhu Y; Liu N; Xiong SD; Zheng YJ; Chu YW
    Scand J Immunol; 2011 Apr; 73(4):301-8. PubMed ID: 21223350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T-cell-specific deletion of gp130 renders the highly susceptible IL-10-deficient mouse resistant to intestinal nematode infection.
    Fasnacht N; Greweling MC; Bollati-Fogolín M; Schippers A; Müller W
    Eur J Immunol; 2009 Aug; 39(8):2173-83. PubMed ID: 19593768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Modeling IL-2 gene expression in human regulatory T cells.
    Benary M; Bendfeldt H; Baumgrass R; Herzel H
    Genome Inform; 2008; 20():222-30. PubMed ID: 19425136
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.